The Department of Chemical Engineering and Biotechnology has been awarded two studentships by the East of England Development Agency (EEDA) for 2009. The awards went to Dr Markus Kraft and Dr Sabine Bahn.
The EEDA is the driving force behind sustainable economic growth and regeneration in the East of England and it administered a competition for Industrial Co-operative Awards in Science and Engineering (ICASE) Studentships for the East of England region on behalf of the Engineering & Physical Sciences Research Council (EPSRC). These studentships are normally allocated to regional small and medium sized companies based within the East of England and enable the company to take the lead in defining projects for students and selecting the academic partner of their choice.
Computational Modelling Cambridge Ltd. (CMCL), a technology-intensive SME will be co-sponsoring one of the studentships at the Computational Modelling (CoMo) Group in this Department. The research project will be "Alt-blend – Alternative fuel based blending strategies for advanced clean Diesel engines". Dr Kraft from the CoMo group said, “We are pleased to accept this prestigious EEDA award which helps us advance our computational research methodologies to solve today’s practical engineering challenges faced by the industry. Dr. Amit Bhave, Chief Executive Officer of CMCL explains, “From practical environmental perspective, alternative fuel blends in advanced clean Diesel engine technologies show promising emissions-reduction potential. As a result of the Alt-blend project, we aim to offer our customers a better understanding of the impact of futuristic fuel-blends on engine performance and emissions, using sophisticated modelling techniques”.
The other award goes to Dr Sabine Bahn of the Cambridge Centre for Neuropsychiatric Research. She said, "We are pleased to accept this prestigious EEDA award which will help us to advance our research into the causes of autism spectrum disorders. It is anticipated that a successful outcome of the project will result in the development of a much-needed diagnostic for improved care of these individuals and may also lead to the development of novel therapeutics".